Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 12, 2021

SELL
$56.65 - $64.55 $437,054 - $498,003
-7,715 Closed
0 $0
Q3 2020

Oct 09, 2020

SELL
$62.1 - $78.08 $252,126 - $317,004
-4,060 Reduced 34.48%
7,715 $488,000
Q2 2020

Jul 21, 2020

SELL
$72.34 - $84.0 $16,348 - $18,984
-226 Reduced 1.88%
11,775 $906,000
Q1 2020

Apr 08, 2020

SELL
$62.63 - $80.22 $174,862 - $223,974
-2,792 Reduced 18.87%
12,001 $897,000
Q4 2019

Jan 22, 2020

SELL
$61.62 - $67.78 $545,398 - $599,920
-8,851 Reduced 37.43%
14,793 $961,000
Q3 2019

Oct 30, 2019

BUY
$62.51 - $69.0 $191,718 - $211,623
3,067 Added 14.9%
23,644 $1.5 Million
Q2 2019

Jul 10, 2019

BUY
$61.87 - $69.38 $75,172 - $84,296
1,215 Added 6.28%
20,577 $1.39 Million
Q1 2019

Apr 24, 2019

BUY
$62.53 - $70.05 $161,327 - $180,729
2,580 Added 15.37%
19,362 $1.26 Million
Q4 2018

Jan 23, 2019

BUY
$60.54 - $79.0 $87,480 - $114,155
1,445 Added 9.42%
16,782 $1.05 Million
Q3 2018

Nov 07, 2018

SELL
$71.28 - $78.92 $173,923 - $192,564
-2,440 Reduced 13.73%
15,337 $1.18 Million
Q2 2018

Jul 11, 2018

SELL
$64.88 - $75.68 $19,464 - $22,704
-300 Reduced 1.66%
17,777 $1.27 Million
Q1 2018

Apr 18, 2018

SELL
$72.84 - $88.8 $24,037 - $29,304
-330 Reduced 1.79%
18,077 $1.36 Million
Q4 2017

Jan 24, 2018

BUY
$71.15 - $83.52 $59,766 - $70,156
840 Added 4.78%
18,407 $1.32 Million
Q3 2017

Nov 08, 2017

BUY
$72.11 - $85.47 $1.27 Million - $1.5 Million
17,567
17,567 $1.42 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Harbour Capital Advisors, LLC Portfolio

Follow Harbour Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Capital Advisors, LLC with notifications on news.